February 2022 Trevena Announces Submission of New Drug Application in China for OLINVYK® by its Partner Jiangsu The NDA was submitted by Trevena’s partner, Jiangsu Nhwa Pharmaceutical, and follows completion by Nhwa

Ji, et al. 2020; L. Wan, 2020). Ji et al., 2020).

Jianming Han , Tao Che  for their analysis of GPCR-G protein selectivity revealed by structural pharmacology

Authors Yaoxin Gao, Weirong Zhan, Dandan Guo, Haizhen Lin, Muhammad Asad Farooq, Chenxu Jin, Li Zhang , Ying Zhou, Jie Yao, Yixin Duan, Cong He, Shuai Jiang, Wenzheng Jiang Tags DCs , GPR97 , Keratinocytes

Authors Miao Guo , Yan Zhang , Lehao Wu , Ye Sheng , Jiaqi Zhao , Zeyuan Wang , Huiyu Wang , Lu Zhang

Authors Yue Xu , Zihan Quan , Yuting Zhan , Haihua Wang , Jiadi Luo , Weiyuan Wang , Songqing Fan Tags